Skip to main content
. 2019 Jul 26;68(29):647–648. doi: 10.15585/mmwr.mm6829a4

TABLE. Comparison of serum concentrations of per- and polyfluoroalkyl substances (PFAS) in the U.S. population with concentrations among participants (N = 30) residing near a PFAS manufacturing facility where PFAS were detected — North Carolina, 2018.

PFAS Abbreviation Limit of detection (LOD) Serum concentrations (μg/L)
Participants (N = 30)
U.S. population*
Median Minimum Maximum Median 95th percentile
2,3,3,3,-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)-propanoate
GenX
0.1
—†


Not measured
perfluorobutane sulfonic acid
PFBS
0.1





perfluorohexanoic acid
PFHxA
0.1



Not measured
perfluorobutanoic acid
PFBA
0.1



Not measured
perfluoroheptanoic acid
PFHpA
0.1


0.6

0.2
perfluoropentanoic acid
PFPeA
0.1



Not measured
4,8-dioxa-3H-perfluorononanoat
ADONA
0.1



Not measured
9-chlorohexadecafluoro-3-oxanonane-1-sulfonate
9Cl-PF3ONS
0.1



Not measured
2-(N-methyl-perfluorooctane sulfonamido) acetic acid
MeFOSAA
0.1


0.6

0.6
perfluorohexane sulfonic acid
PFHxS
0.1
2.1
0.7
6.7
1.2
4.9
linear perfluorooctanoic acid
n-PFOA
0.1
1.8
0.4
7.3
1.5
4.1
branched perfluorooctanoic acids
Sb-PFOA
0.1





perfluorodecanoic acid
PFDA
0.1
0.2

1.3
0.1
0.7
perfluoroundecanoic acid
PFUnDA
0.1


0.5

0.4
perfluoromethylheptane sulfonic acids (methyl branched PFOS)
Sm-PFOS
0.1
1.2
0.2
7.4
1.5
5.7
linear perfluorooctane sulfonic acid
n-PFOS
0.1
5.5
1.4
34.6
3.2
12.8
perfluorononanoic acid PFNA 0.1 0.6 2.1 0.6 1.9

* CDC. Fourth national report on human exposure to environmental chemicals: updated tables, January 2019, volume one. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Volume1_Jan2019-508.pdf.

Below the LOD (applies to all of the dashes in cells of the table).